Study 1 of 3 for search of: "Hoarseness"
Previous Study Return to Search Results Next Study

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Screening for Barrett's Esophagus in Otolaryngology Patients (SCE)
This study is currently recruiting participants.
Verified by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), December 2008
Sponsored by: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
ClinicalTrials.gov Identifier: NCT00695227
  Purpose

The purpose of this project is to develop an accurate method to identify patients that suffer from acid reflux, but may not present with classic reflux symptoms (such as heart burn). Additionally, it is the purpose of this project to utilize the Unsedated Small-caliber Endoscopy (USE) to assess the prevalence of Barrett's esophagus in a population of patients with laryngopharyngeal reflux (LPR) symptoms and to define normal patterns of LPR. Laryngopharyngeal reflux (LPR) is when a small amount of stomach contents and acid are pushed up through the esophagus and may affect the vocal cords and upper respiratory tract.

It is suspected that patients with LPR symptoms may have a prevalence of Barrett's esophagus similar to that found in a population with typical reflux symptoms. We propose to systematically test this hypothesis using the USE.

This project is designed to improve the methods of identifying patients with a form of acid reflux that is often undetected, and thus untreated. If this project is successful then more patients with Barrett's esophagus will be identified; furthermore, screening and treatment for this pre-cancerous condition will be improved.


Condition Intervention Phase
Extra Esophageal Symptoms:
Cough
Throat Clearing
Hoarseness
Difficulty Swallowing
Drug: Proton Pump Inhibitor
Phase II

MedlinePlus related topics: Cough Swallowing Disorders
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study
Official Title: Screening for Barrett's Esophagus in Otolaryngology Patients

Further study details as provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):

Primary Outcome Measures:
  • The primary aim of the study is to establish that patients with symptoms of LPR who are referred to an otolaryngology clinic have a prevalence of Barrett's metaplasia equivalent to that of a population with GERD symptoms. [ Time Frame: One time ] [ Designated as safety issue: No ]

Estimated Enrollment: 500
Study Start Date: May 2004
Estimated Study Completion Date: November 2013
Estimated Primary Completion Date: November 2008 (Final data collection date for primary outcome measure)
Intervention Details:
    Drug: Proton Pump Inhibitor
    Screened patients with extraesophageal reflux symptoms will be followed prospectively in order to gauge response to acid suppressing medication treatment. Non-responders will be tested with pharyngeal pH monitoring.
  Eligibility

Ages Eligible for Study:   18 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

-

Exclusion Criteria:

  • Prior anti-reflux surgery, laryngeal surgery, trauma to larynx Esophageal diverticulum Pregnancy Anticoagulation therapy Esophageal varices ENT malignancy History of recurrent epistaxis
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00695227

Locations
United States, Oregon
Oregon Health & Science University Recruiting
Portland, Oregon, United States, 97239-3098
Contact: Stevie Jepsen, BS     503-494-8164        
Principal Investigator: Joshua Schindler, MD            
Sponsors and Collaborators
Investigators
Principal Investigator: Joshua Schindler, MD Oregon Health and Science University
  More Information

Responsible Party: Oregon Health & Science University ( Joshua Schindler )
Study ID Numbers: DK66165, DK066165-02
Study First Received: June 6, 2008
Last Updated: December 1, 2008
ClinicalTrials.gov Identifier: NCT00695227  
Health Authority: United States: Food and Drug Administration;   United States: Federal Government

Keywords provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):
laryngopharyngeal reflux
extraesophageal reflux symptoms

Study placed in the following topic categories:
Otorhinolaryngologic Diseases
Esophageal disorder
Gastrointestinal Diseases
Hoarseness
Respiration Disorders
Cough
Pharyngeal Diseases
Deglutition Disorders
Signs and Symptoms
Digestive System Abnormalities
Digestive System Diseases
Respiratory Tract Diseases
Signs and Symptoms, Respiratory
Neurologic Manifestations
Barrett Esophagus
Esophageal Diseases
Voice Disorders
Laryngeal Diseases
Congenital Abnormalities

Additional relevant MeSH terms:
Nervous System Diseases

ClinicalTrials.gov processed this record on January 16, 2009